Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2019

    2019 World Conference on Lung Cancer

    Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain

    Presentation Date(s):  
    • Sept 7 - 10, 2019
    • Total Presentations: 2848

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    EP1.16 - Treatment in the Real World - Support, Survivorship, Systems Research

    • Type: E-Poster Viewing in the Exhibit Hall
    • Track: Treatment in the Real World - Support, Survivorship, Systems Research
    • Presentations: 1
    • Now Available
    • Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
    • +

      EP1.16-27 - Observational Study to Investigate the Implementation Rate of Re-Biopsy in EGFR-TKI-Resistant Patients (NLCTG1602) (Now Available)

      08:00 - 08:00  |  Author(s): KENICHI Koyama

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.14 - Targeted Therapy

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Targeted Therapy
    • Presentations: 0
    • Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
    • +

      P2.14-52 - The Results from Plasma EGFR Mutation Analysis in NEJ026 Study

      10:15 - 10:15  |  Presenter: Tatsuro Fukuhara

      • Abstract

      Loading...

  • +

    MA21 - Non EGFR/MET Targeted Therapies

    • Type: Mini Oral Session
    • Track: Targeted Therapy
    • Presentations: 1
    • Now Available
    • Moderators:Benjamin Besse
    • Coordinates: 9/10/2019, 14:30 - 16:00, Vienna (2016)
    • +

      MA21.05 - Phase II Trial of the Combination of Alectinib with Bevacizumab in ALK-Positive Nonsquamous Non-Small Cell Lung Cancer (Now Available)

      15:00 - 15:05  |  Presenter: Satoshi Watanabe

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.